The Research and Development Team at QPS Neuropharmacology is dedicated to advancing preclinical studies related to central nervous system (CNS) diseases and mental disorders. They design and execute innovative research protocols, conduct comprehensive studies, and analyze data to evaluate the efficacy and safety of new neuropharmacological compounds, ultimately contributing to the development of effective treatments in these critical therapeutic areas.
View all